121 related articles for article (PubMed ID: 6792646)
1. Non-interference by salicylate with aspirin inhibition of arterial thrombosis in rats.
Philp RB; Paul ML
Prostaglandins Med; 1981 Aug; 7(2):91-4. PubMed ID: 6792646
[TBL] [Abstract][Full Text] [Related]
2. The influence of dose, time of administration, body temperature and salicylate kinetics on the antithrombotic action of acetylsalicylic acid in male rats.
Philp RB; Paul ML; Killackey JJ; Killackey BA
Haemostasis; 1983; 13(1):42-52. PubMed ID: 6404714
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of aspirin and sodium salicylate.
Amann R; Peskar BA
Eur J Pharmacol; 2002 Jun; 447(1):1-9. PubMed ID: 12106797
[TBL] [Abstract][Full Text] [Related]
4. [The modes of anti-inflammatory and analgesic actions of aspirin and salicylic acid].
Higuchi S; Osada Y; Shioiri Y; Tanaka N; Otomo S; Aihara H
Nihon Yakurigaku Zasshi; 1985 Jan; 85(1):49-57. PubMed ID: 3921440
[TBL] [Abstract][Full Text] [Related]
5. ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without "aspirin dilemma".
Sakata C; Kawasaki T; Kato Y; Abe M; Suzuki K; Ohmiya M; Funatsu T; Morita Y; Okada M
Thromb Res; 2013 Jul; 132(1):56-62. PubMed ID: 23522855
[TBL] [Abstract][Full Text] [Related]
6. Effect of aspirin and sodium salicylate on thrombosis, fibrinolysis, prothrombin time, and platelet survival In rabbits with indwelling aortic catheters.
Cattaneo M; Chahil A; Somers D; Kinlough-Rathbone RL; Packham MA; Mustard JF
Blood; 1983 Feb; 61(2):353-61. PubMed ID: 6821701
[TBL] [Abstract][Full Text] [Related]
7. Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation.
Merino J; Livio M; Rajtar G; de Gaetano G
Biochem Pharmacol; 1980 Apr; 29(8):1093-6. PubMed ID: 6770871
[No Abstract] [Full Text] [Related]
8. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.
Dejana E; Cerletti C; de Castellarnau C; Livio M; Galletti F; Latini R; de Gaetano G
J Clin Invest; 1981 Oct; 68(4):1108-12. PubMed ID: 6793630
[TBL] [Abstract][Full Text] [Related]
9. Sodium salicylate interferes with the inhibitory effects of aspirin and indomethacin on human platelets.
Dahl ML; Puustinen T; Uotila P
Prostaglandins Leukot Med; 1983 Sep; 12(1):21-8. PubMed ID: 6415666
[TBL] [Abstract][Full Text] [Related]
10. Effects of aspirin dosage and time of administration on arterial prostacyclin production and platelet aggregation in rats.
Philp RB; Paul ML
Prostaglandins Leukot Med; 1984 Jul; 15(1):91-102. PubMed ID: 6382343
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function.
Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G
J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057
[TBL] [Abstract][Full Text] [Related]
12. The combined effects of sodium salicylate, aspirin and indomethacin on the metabolism of arachidonic acid in human platelets.
Dahl ML; Uotila P
Prostaglandins Leukot Med; 1984 Oct; 16(1):95-107. PubMed ID: 6440154
[TBL] [Abstract][Full Text] [Related]
13. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
[TBL] [Abstract][Full Text] [Related]
14. Superior activity of a thromboxane receptor antagonist as compared with aspirin in rat models of arterial and venous thrombosis.
Schumacher WA; Heran CL; Steinbacher TE; Youssef S; Ogletree ML
J Cardiovasc Pharmacol; 1993 Oct; 22(4):526-33. PubMed ID: 7505353
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and salicylate enhances the induction of inducible nitric oxide synthase in cultured rat smooth muscle cells.
Nishio E; Watanabe Y
Life Sci; 1998; 63(6):429-39. PubMed ID: 9718067
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity.
Higgs GA; Salmon JA; Henderson B; Vane JR
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1417-20. PubMed ID: 3103135
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and other cyclooxygenase inhibitors: new therapeutic insights.
Wu KK
Semin Vasc Med; 2003 May; 3(2):107-12. PubMed ID: 15199473
[TBL] [Abstract][Full Text] [Related]
18. Novel actions of aspirin and sodium salicylate: discordant effects on nitric oxide synthesis and induction of nitric oxide synthase mRNA in a murine macrophage cell line.
Kepka-Lenhart D; Chen LC; Morris SM
J Leukoc Biol; 1996 Jun; 59(6):840-6. PubMed ID: 8691069
[TBL] [Abstract][Full Text] [Related]
19. Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in rats.
Barnes CJ; Hardman WE; Cameron IL; Lee M
Dig Dis Sci; 1997 May; 42(5):920-6. PubMed ID: 9149043
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.
de Gaetano G; Cerletti C; Dejana E; Latini R
Circulation; 1985 Dec; 72(6):1185-93. PubMed ID: 2998640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
